The Fasting-Mimicking Diet (FMD): What Is It and What Does the Research Actually Show?

The fasting-mimicking diet (FMD) is a nutrition protocol developed by Prof. Valter Longo's team at the University of Southern California, typically lasting five days, in which a small amount of food is consumed — roughly 700-1100 kcal a day, low in protein and carbohydrates and high in unsaturated fats — instead of giving up food entirely. The idea is that this specifically composed, strictly limited meal plan tricks the body into "thinking" it's fasting and activates metabolic pathways similar to those seen in full water fasting, while reducing the risk and discomfort of complete food deprivation.

FMD gained widespread attention through the commercial product ProLon — a ready-made five-day meal kit developed by L-Nutra, a company co-founded by Longo himself. That's important context to keep in mind while reading research on the topic: a substantial portion of the scientific literature on FMD comes from Longo's lab or is funded by or linked to L-Nutra, which doesn't invalidate the results, but does call for factoring in the potential conflict of interest when interpreting them.

This distinction has practical significance: FMD isn't a "gentler" version of water fasting created purely for convenience, but a separately designed protocol in which the specific composition and amount of food consumed is meant to be part of the mechanism of action, not just a concession to comfort. That doesn't mean FMD is automatically "better" than water fasting in every context — most comparative studies come from animal models, and there are still few direct head-to-head studies in humans.

It's worth highlighting what this study actually shows and what it doesn't. It shows that short, repeated FMD cycles are mostly safe and feasible in healthy adults and affect measurable metabolic markers. It does not show that FMD extends lifespan in humans, prevents specific chronic diseases, or works better than other forms of calorie restriction — those questions would require much longer studies with hard endpoints, which are still lacking.

The commercial ProLon kit is a ready-made set of precisely weighed meals for five days, designed to replicate the macronutrient ratios used in Longo's studies. Its advantages are convenience and consistency with the composition used in the research protocol; its downside is the price, usually significantly higher than the cost of self-prepared, comparable low-calorie, low-protein meals.

In theory, it's possible to replicate a similar protocol on your own — low calorie intake (roughly 700-1100 kcal a day), low protein, a high share of unsaturated fats and low-glycemic-index complex carbohydrates over 5 days. In practice, though, no clinical trial has directly tested homemade FMD equivalents against ProLon — so there's no direct evidence that a self-designed plan produces identical metabolic effects to the exact protocol that was studied. That's an important caveat when weighing the cost against the potential benefit.

Despite a growing number of studies, the FMD literature has several notable limitations. First, a substantial portion of the research comes from the same research team (Longo and colleagues) or is linked to the commercial manufacturer ProLon, which doesn't disqualify the results but does call for more interpretive caution than with independently replicated studies. Second, most studies to date have relatively small sample sizes (a few dozen to a couple hundred participants) and assess intermediate markers (IGF-1, blood glucose, body weight) rather than hard endpoints such as long-term mortality or chronic disease incidence.

Third, the long-term safety of repeated, monthly FMD cycles used for years — rather than just over a study period of a few months to a year — remains poorly studied. Finally, effects observed in mouse studies (e.g., regeneration of intestinal stem cells) don't always translate directly to humans at the same scale, and some of the enthusiastic claims about FMD popular in the media go beyond what clinical studies in humans have actually shown.

FMD is one of the few popular nutrition protocols actually backed by a growing body of clinical research, including at least one solid, fully randomized one-year trial in a real-world population. That sets it apart from many diet trends based mostly on anecdote. At the same time, a large share of that literature comes from a single research team linked to a commercial product, and studies with hard endpoints in humans remain scarce — which justifies cautious enthusiasm rather than uncritical acceptance of the marketing promises.